Skip to main content
Research Center for Molecular Medicine of the Austrian Academy of Sciences
CD Laboratory for Chemical Epigenetics and Antiinfectives
FFG Bridge "ImmunoDegraders"
FWF DK W 1212-B21 "IAI"
FWF International I4768 "Resetting the Epigenetic Status of the DM1Locus"
FWF International I5133 "Discovery of chemotherapeutic lead-compounds in cynobacteria"
FWF 1000 Ideas TAI289 "The Human Mini-Cell"
FWF SFB F 6102-B21 "Chromatin Landscapes"
FWF SFB F 7002-B21 "HDACs as regulators of T cell-mediated immunity in health and disease"
FWF SFB F 7909-B "Chemical probing and functional characterization of the E3 substrate receptor DCAF15"
FWF Stand-Alone P 32125-B
FWF Stand-Alone P 31690-B28
FWF START Y1037
OeAW New Frontier Group 2013
OeAW NFRI 2015
OeAW Innovationsfonds "KRAScondensate"
WWTF LS18 - 058 "Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice"
WWTF LS18 - 049 "Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy"
WWTF LS20 - 034 "Decoding cellular senescence in glioblastoma"
WWTF LS20 - 045 "LiquidBiopsyKids: Validation of a liquid biopsy based molecular diagnostic toolkit for pediatric sarcomas"
WWTF LS20 - 065 "PREDICTOME: Precision medicine for breast cancer: multi-omics towards predicting complete remission and avoiding surgery"
WWTF LS18 Life Sciences Call
Duration 2019 - 2023
Christoph Bock's Group
Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy